HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 53 filers reported holding HARPOON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,130,267 | $43,417,000 | 8.07% |
| MPM BioImpact LLC | 3,196,707 | $44,338,000 | 7.28% |
| Aquilo Capital Management, LLC | 712,674 | $9,885,000 | 2.57% |
| Logos Global Management LP | 800,000 | $11,096,000 | 0.93% |
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $3,364,000 | 0.86% |
| VR Adviser, LLC | 512,005 | $7,102,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 580,759 | $8,055,000 | 0.65% |
| Avidity Partners Management LP | 1,500,000 | $20,805,000 | 0.56% |
| Orbimed Advisors | 2,611,308 | $36,219,000 | 0.37% |
| Maven Securities LTD | 618,610 | $8,456,000 | 0.34% |